ClinicalTrials.Veeva

Menu

Percutaneous Translumbar Vs Transhepatic Permcath

A

Assiut University

Status

Not yet enrolling

Conditions

End Stage Renal Disease

Treatments

Procedure: Percutaneous translumbar and transhepatic permcath

Study type

Interventional

Funder types

Other

Identifiers

NCT05666375
Unconventional permcath

Details and patient eligibility

About

The aim of the study is to emphasize the technique , success rate , efficacy of translumbar and transhepatic approaches and shed light on the complications of both methods and through comparison we can give recommendations to either of these methods.

Full description

For selected ESRD patients who have exhausted all conventional access routes , translumbar and transhepatic permcath provide additional sites for access. This study will compare the two methods in terms of technical success (position of catheter tip), patency (primary defined as the number of catheter days from initial placement until removal & secondary defined as the number of catheter days after device replacement using the same access site) , mean cumulative duration of catheter in situ defined as the cumulative catheter days divided by the number of patients, function (adequacy of dialysis based on Urea Reduction Ratio URR & Simplified Daugirdas Formula Kt/V) and complications (infectious; exit site infection & sepsis and non-infectious; thrombosis, catheter migration, hematoma, intraperitoneal hemorrhage.

Enrollment

52 estimated patients

Sex

All

Ages

5 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic dialysis patients with failed classic routes of catheterization ( internal jugular, subclavian and femoral veins bilaterally ) as well as non-functioning a-v fistulas.

Exclusion criteria

  1. Patients with uncorrectable coagulopathy.
  2. Patients on long term anticoagulants
  3. Concurrent active infection.
  4. Sgnificant abdominal ascites. (transhepatic)
  5. Cirrhotic liver disease patients. (transhepatic)
  6. Morbid obesity. (translumbar)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

52 participants in 2 patient groups

Percutaneous translumbar permcath
Active Comparator group
Description:
* Local anesthesia in adults and general anesthesia in pediatrics. * The patient under fasting condition is placed prone on angiography table. * Skin preparation and a sterile draping of the operating field. * Puncture site is chosen 1.5 cm above right iliac crest 10 cm lateral to the posterior median line. * Puncture into inferior vena cava is made using 21 gauge 15 cm long needle, inserted at 45 degree angle from the horizontal and advanced medially and superiorly under us then fluoroscopic guidance. * Entry into the IVC is made below the level of the renal veins, immediately anterior to the 3rd lumber vertebra. * Intravascular position of the needle is confirmed by free aspiration of blood and injection of contrast media under fluoroscopy. * A guide wire is introduced through the needle and advanced well into the IVC. * The needle is replaced with a dilator. A catheter of appropriate length is tunneled subcutaneously from the right flank and advanced to the IVC
Treatment:
Procedure: Percutaneous translumbar and transhepatic permcath
Percutaneous transhepatic permcath
Active Comparator group
Description:
* The patient lies in supine position. * The procedure is done under local anesthesia. * Under ultrasound guidance; access by a 21 gauge angiocatheter (15cm) to right or middle hepatic vein through intercostal or subcostal approach. * Entrance of the hepatic veins is confirmed by injection of diluted contrast media (iopromide) under fluoroscopy. * A 0.018-inch guidewire is advanced through the needle and into the right atrium. Intravascular catheter length is measured and selected in standard fashion. * The initial access needle is exchanged over the guidewire for a coaxial transitional sheath, which permits replacement of the 0.018-inch guidewire with a 0.035-inch guidewire. * The tunneled catheter is inserted over the wire through a peel-away sheath
Treatment:
Procedure: Percutaneous translumbar and transhepatic permcath

Trial contacts and locations

0

Loading...

Central trial contact

Hany Seif; Abdallah Morsy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems